Quick answer: Estradiol is the most potent naturally occurring estrogen and plays a key role in maintaining pelvic floor health. When estradiol levels decline—most commonly during menopause—the urogenital tissues can weaken, leading to conditions like vaginal atrophy, urinary incontinence, and pelvic organ prolapse. Hormone replacement therapy and pelvic floor muscle therapy can both help address these changes.
Pelvic floor health is one of those topics that doesn’t get nearly enough attention—until something goes wrong. Experiencing urinary leakage, painful intercourse, or a persistent sense of pressure in the pelvic region can feel isolating. But these symptoms are far more common than most people realize, and in many cases, they trace back to a single, surprisingly powerful hormone: estradiol.
Understanding how estradiol interacts with the pelvic floor is a meaningful step toward finding real relief. This post breaks down what estradiol is, what happens when levels drop, and how hormone replacement therapy (HRT) and pelvic floor muscle therapy can work together to support your health.
What Is Estradiol, and Why Does It Matter?
Estradiol is the most potent form of naturally occurring estrogen. Produced primarily in the ovaries, it plays a central role in regulating reproductive function, bone density, cardiovascular health, and the integrity of soft tissues throughout the body—including the pelvic floor.
What makes estradiol particularly relevant to pelvic health is where its receptors are found. According to a committee opinion published in the International Urogynecology Journal (Bodner-Adler et al., 2019), estradiol receptors (ERs) are present in the squamous epithelium of the urethra, vagina, bladder trigone, and anal canal, as well as in the urethral sphincter, uterosacral ligaments, and pelvic floor musculature. In short, estradiol has a direct line of influence over nearly every tissue involved in pelvic floor function.
Estradiol also supports vaginal blood flow and helps maintain the low pH environment of the vagina—conditions that protect against infection and keep tissues resilient and well-hydrated.
How Do the Pelvic Floor Muscles Function—and What Can Go Wrong?
The pelvic floor is a group of muscles, ligaments, and connective tissues that form the base of the pelvis. These structures support the bladder, bowel, and reproductive organs, help regulate continence, and play a significant role in sexual function and sensation.
Pelvic floor dysfunction (PFD) can take two broad forms. When the muscles are too weak, symptoms may include a feeling of looseness, difficulty controlling the bladder or bowel, or pelvic organ prolapse (POP)—a condition where pelvic organs begin to descend into or through the vaginal canal. When the muscles are too tight or overactive, they can contribute to pelvic and vaginal pain, painful intercourse (dyspareunia), and conditions like vulvodynia or vestibulodynia.
Both presentations are linked to female sexual dysfunction (FSD). Pelvic floor muscle tone affects the quality of sexual sensation, the ability to experience comfortable penetration, and the capacity for muscle relaxation and contraction during intimacy.
What Happens to the Pelvic Floor When Estradiol Levels Drop?
The most common cause of estradiol decline is menopause. As ovarian function decreases, estradiol production falls—and the pelvic tissues feel it. Hormonal changes during gender-affirming care can also result in estradiol deficiency.
When estradiol is no longer present in adequate amounts, several changes can unfold in the urogenital tract:
Vaginal atrophy (vulvovaginal symptoms, or VVS): The vaginal walls thin and lose elasticity. This can cause burning, dryness, itching, and painful intercourse. According to Bodner-Adler et al. (2019), the majority of studies confirm that vaginal estrogen treatment significantly reduces these symptoms compared to placebo.
Urinary symptoms: Low estradiol is associated with overactive bladder (OAB), urinary urgency, frequency, nocturia, and urinary incontinence (UI). The tissues lining the urethra and bladder are estrogen-responsive, so without adequate estrogen, their function can be compromised. A 2014 systematic review of 44 individual clinical studies found that all available vaginal estrogen preparations reduce lower urinary tract symptoms, including urgency, frequency, and voiding dysfunction.
Pelvic organ prolapse (POP): Estrogen helps regulate collagen production in the connective tissue supporting the pelvic organs. Without it, that connective tissue can weaken—contributing to prolapse. Research has also shown that estrogen suppresses certain enzymes that break down collagen, meaning lower estradiol levels may accelerate tissue degradation.
How Does Estradiol-Based HRT Support Pelvic Floor Health?
HRT works by supplementing hormones that have declined—commonly estrogen, progestin, or testosterone. When it comes to pelvic floor disorders specifically, the form of estradiol matters considerably.
Local estrogen therapy (LET) applies estradiol directly to the vaginal tissues. It’s available as a cream, insert, ring, or gel (such as brands like Estrace, Estring, Vagifem, and Imvexxy). Because the hormone is absorbed locally rather than systemically, LET delivers targeted benefits with minimal systemic exposure.
The evidence for local estrogen is meaningful. A 2014 systematic review concluded that all commercially available vaginal estrogens effectively relieve vulvovaginal atrophy-related symptoms and offer additional benefits for urinary urgency, frequency, stress urinary incontinence, and recurrent UTIs (Rahn et al., 2014). In one randomized trial comparing an estradiol-releasing vaginal ring to oral oxybutynin for OAB, women using the estradiol ring saw a decrease of 4.5 voids per day—comparable to the medication, but without the anticholinergic side effects.
For those with pelvic organ prolapse, ongoing research is investigating whether vaginal estrogen can reduce the recurrence of prolapse after surgical repair. A pilot study conducted at UT Southwestern found that vaginal estrogen used prior to surgery improved the resilience of pelvic floor connective tissue—a promising early finding that has since led to a larger clinical trial (IMPROVE).
Systemic HRT, however, tells a different story when it comes to urinary symptoms. Research from the Women’s Health Initiative (WHI) demonstrated that both estrogen-only and combined estrogen-progestin systemic HRT were associated with a statistically significant increase in risk for urinary incontinence and, in some cases, the development of new-onset UI. Systemic HRT is therefore not recommended for treating or preventing urinary incontinence, even though it may benefit other aspects of health.
The takeaway? Local estrogen therapy appears safe and effective for vaginal and urinary symptoms in postmenopausal patients. Systemic HRT requires careful conversation with a healthcare provider, particularly for those already managing urinary symptoms.
Why Combining HRT with Pelvic Floor Muscle Therapy Often Works Best
Hormone therapy addresses the tissue-level changes—but it doesn’t directly retrain the muscles. That’s where pelvic floor muscle (PFM) therapy comes in.
PFM therapy, by a trained pelvic floor physical therapist, targets the tone and coordination of the pelvic floor. You can strengthen muscles that have weakened, release muscles that are overactive, and improve the quality of contractions and relaxation during daily activities and sexual function. Clinical evidence supports its use for chronic pelvic pain, bowel and bladder incontinence, and FSD (SMSNA, 2025).
When used alongside hormonal support, PFM therapy may offer compounding benefits. Better-quality tissue responds more effectively to rehabilitation. Reduced inflammation and improved tissue hydration from local estrogen can make pelvic floor exercises more comfortable and productive. The two approaches, combined thoughtfully, address the problem from multiple angles.
Taking the Next Step for Your Pelvic Floor Health
Pelvic floor symptoms—whether that’s leakage, pain, prolapse, or sexual discomfort—are not something you need to navigate alone, and they are certainly not an inevitable part of aging. Estradiol plays a foundational role in keeping the pelvic tissues healthy, and when levels decline, targeted treatments exist that can genuinely help.
If you’d like personalized guidance on how hormones and pelvic floor function intersect for your specific situation, schedule an appointment with Sherryl DeVries at Relax Therapy. As a pelvic floor physical therapist with expertise in vaginal health, I can work with you to create a plan that supports your comfort, function, and quality of life.
Frequently Asked Questions
What is estradiol and how is it different from other forms of estrogen?
Estradiol is the most biologically potent of the naturally occurring estrogens. It’s produced primarily in the ovaries and is the dominant form of estrogen during the reproductive years. Estrone and estriol are the other main forms; estrone becomes more prominent after menopause, while estriol is produced mainly during pregnancy. Estradiol is more active at the tissue level, which is why its decline has such noticeable effects on pelvic health.
Can low estradiol cause urinary incontinence?
Yes. Estradiol receptors are found in the urethra and bladder. When estradiol levels drop, these tissues can become less responsive and less structurally supported, contributing to symptoms like urgency, frequency, and leakage. Local estrogen therapy has been shown to improve these symptoms in postmenopausal patients.
Is local estrogen therapy safe for long-term use?
Local estrogen therapy delivers estradiol directly to the vaginal tissue, meaning systemic absorption is minimal. Research to date suggests it is well-tolerated, with no significant adverse events reported in studies of topical estrogen use. However, it’s important to discuss your individual health history with a qualified provider before starting any hormone therapy.
What’s the difference between local estrogen and systemic HRT for pelvic floor disorders?
Local estrogen (vaginal cream, ring, insert, or gel) targets the urogenital tissues specifically and is generally recommended for vaginal atrophy, urinary symptoms, and recurrent UTIs. Systemic HRT enters the bloodstream and affects the whole body—it can be helpful for hot flashes and bone health, but studies have shown it may worsen urinary incontinence in some people. For pelvic floor disorders, local estrogen is generally the preferred approach.
How do I know if pelvic floor muscle therapy is right for me?
PFM therapy may help if you’re experiencing urinary or bowel leakage, pelvic pain, pain during intercourse, or symptoms of prolapse. A pelvic floor physical therapist can assess your muscle tone, coordination, and strength and develop a personalized program. Many people find it most effective when combined with appropriate hormonal support.